294 related articles for article (PubMed ID: 27977628)
1. Percutaneous Irreversible Electroporation for Pancreatic VIPoma: A Case Report.
Niu L; Li J; Zeng J; Fang G; Zhou L; Xu K; Zhang K
Pancreas; 2017 Jan; 46(1):135-137. PubMed ID: 27977628
[TBL] [Abstract][Full Text] [Related]
2. Sporadic pancreatic vasoactive intestinal peptide-producing tumor (VIPoma) in a 47-year-old male.
Abu-Zaid A; Azzam A; Abudan Z; Algouhi A; Almana H; Amin T
Hematol Oncol Stem Cell Ther; 2014 Sep; 7(3):109-15. PubMed ID: 24785507
[TBL] [Abstract][Full Text] [Related]
3. [Pancreatic vipoma with bizarre characteristics].
Bermejo F; Moreno L; Moreira V; Gisbert JP; González Palacios F; García López JL
Gastroenterol Hepatol; 1999 Mar; 22(3):132-5. PubMed ID: 10228323
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and treatment of pancreatic vasoactive intestinal peptide endocrine tumors.
Song S; Shi R; Li B; Liu Y
Pancreas; 2009 Oct; 38(7):811-4. PubMed ID: 19657309
[TBL] [Abstract][Full Text] [Related]
5. [Diagnosis and treatment of vasoactive intestinal peptide-secreting-tumors: one case report and 15 years review in China].
Li JT; Peng SY; Liu YB; Fang HQ; Wu YL; Wang XB; Tang Z; Qian HR; Ji C
Zhonghua Wai Ke Za Zhi; 2004 May; 42(9):524-7. PubMed ID: 15196363
[TBL] [Abstract][Full Text] [Related]
6. [Metastasizing pancreatic vipoma. Its diagnosis and therapy with the somatostatin analog octreotide].
Scheffold N; Arnold R; Cyran J
Dtsch Med Wochenschr; 1995 Oct; 120(43):1463-7. PubMed ID: 7588006
[TBL] [Abstract][Full Text] [Related]
7. VIPoma with expression of both VIP and VPAC1 receptors in a patient with WDHA syndrome.
Nakayama S; Yokote T; Kobayashi K; Hirata Y; Hiraiwa T; Komoto I; Miyakoshi K; Yamakawa Y; Takubo T; Tsuji M; Imamura M; Hanafusa T
Endocrine; 2009 Apr; 35(2):143-6. PubMed ID: 19184565
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic vasoactive intestinal polypeptide-oma as a cause of secretory diarrhoea.
Masel SL; Brennan BA; Turner JH; Cullingford GL; Cullen DJ
J Gastroenterol Hepatol; 2000 Apr; 15(4):457-60. PubMed ID: 10824894
[TBL] [Abstract][Full Text] [Related]
9. VIPomas: an update in diagnosis and management in a series of 11 patients.
Nikou GC; Toubanakis C; Nikolaou P; Giannatou E; Safioleas M; Mallas E; Polyzos A
Hepatogastroenterology; 2005; 52(64):1259-65. PubMed ID: 16001675
[TBL] [Abstract][Full Text] [Related]
10. Intractable and dramatic diarrhea in liver transplantation recipient with vasoactive intestinal peptide-producing tumor after split liver transplantation: a case report.
Haiqing W; Jiayin Y; Jian Y; Lunan Y
Transplant Proc; 2015; 47(1):171-3. PubMed ID: 25596962
[TBL] [Abstract][Full Text] [Related]
11. Amelioration of symptoms and reduction of VIP levels after hepatic artery chemoembolization in a patient with sandostatin resistant VIPoma.
Shaib W; Mitchell K; Saif MW
Yale J Biol Med; 2010 Mar; 83(1):27-33. PubMed ID: 20351979
[TBL] [Abstract][Full Text] [Related]
12. Vasoactive Intestinal Peptide-Secreting Tumors: A Review.
Siddappa PK; Vege SS
Pancreas; 2019 Oct; 48(9):1119-1125. PubMed ID: 31609932
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and treatment of VIPoma in China: (case report and 31 cases review) diagnosis and treatment of VIPoma.
Peng SY; Li JT; Liu YB; Fang HQ; Wu YL; Peng CH; Wang XB; Qian HR
Pancreas; 2004 Jan; 28(1):93-7. PubMed ID: 14707737
[TBL] [Abstract][Full Text] [Related]
14. Clinical problem-solving. Needle in a haystack.
Kapoor R; Moseley RH; Kapoor JR; Crapo LM; Saint S
N Engl J Med; 2009 Feb; 360(6):616-21. PubMed ID: 19196679
[No Abstract] [Full Text] [Related]
15. Pancreatic Neuroendocrine Tumor Secreting Vasoactive Intestinal Peptide and Dopamine With Pulmonary Emboli: A Case Report.
Nilubol N; Freedman EM; Quezado MM; Patel D; Kebebew E
J Clin Endocrinol Metab; 2016 Oct; 101(10):3564-3567. PubMed ID: 27583474
[TBL] [Abstract][Full Text] [Related]
16. [Diagnosis and treatment of pancreatic islet cell tumors producing vasoactive intestinal polypeptide (VIPoma)].
Kábrt J; Dvorák M; Skrha J; Sindelka G
Vnitr Lek; 1999 Oct; 45(10):606-9. PubMed ID: 10951870
[TBL] [Abstract][Full Text] [Related]
17. VIPoma syndrome.
Krejs GJ
Am J Med; 1987 May; 82(5B):37-48. PubMed ID: 3035922
[TBL] [Abstract][Full Text] [Related]
18. Safety of Irreversible Electroporation Ablation of the Pancreas.
Lee EW; Shahrouki P; Peterson S; Tafti BA; Ding PX; Kee ST
Pancreas; 2021 Oct; 50(9):1281-1286. PubMed ID: 34860812
[TBL] [Abstract][Full Text] [Related]
19. An Unusual Cause of Watery Diarrhea.
Nassani N; Melitas C; Villa E
Gastroenterology; 2021 Feb; 160(3):671-674. PubMed ID: 33039475
[No Abstract] [Full Text] [Related]
20. Ablation of Locally Advanced Pancreatic Cancer with Percutaneous Irreversible Electroporation: Results of the Phase I/II PANFIRE Study.
Scheffer HJ; Vroomen LG; de Jong MC; Melenhorst MC; Zonderhuis BM; Daams F; Vogel JA; Besselink MG; van Kuijk C; Witvliet J; de van der Schueren MA; de Gruijl TD; Stam AG; van den Tol PM; van Delft F; Kazemier G; Meijerink MR
Radiology; 2017 Feb; 282(2):585-597. PubMed ID: 27604035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
